The lactate accumulation method was used to design lactate-responsive vectors containing lactate oxidase (LOX) and AAV2, which reduced pH and viral infection, as well as increased apoptosis when both LOX and lactate were presented in the formulation (Tseng et al., 2018). The gene discussed is LOX; the disease is viral infectious disease.